Novel potential medulloblastoma risk loci at 18p11.23. »
12/12/19

Rare heterozygous germline variant c.853delT (p.Ter285Lysfs) rs77179853 identified. »
10/14/19

PID associated with increased risk of ovarian cancer. »
12/16/19

BBN treatment significantly enhanced expression of proinflammatory molecules and accelerated disease development. »
01/15/20

Periostin confirmed to be independent prognostic marker for breast cancer-specific survival. »
01/08/20

Knock-down of KMT9α inhibits lung cancer cell proliferation. »
02/17/20

Combination strategies with BRAFi and ErbBi achieved better response. »
02/17/20

Small RNA-based classifier predictive of response to preoperative Let/Bev developed and confirmed. »
02/18/20

Limited evidence of heterogeneity in associations between circulating 27HC and breast cancer risk. »
02/19/20

Group pre-test genetic counselling combined with immediate “mini” individual session strongly supported by patients. »
02/19/20